Please use this identifier to cite or link to this item:
http://hdl.handle.net/123456789/9577
Title: | HIV-1-Specific Enzyme-Linked Immunosorbent Spot Assay Responses in HIV-1-Exposed Uninfected Partners in Discordant Relationships Compared to Those in Low-Risk Controls |
Authors: | Guthrie, Brandon L. Lohman-Payne, Barbara Liu, Amy Y. Bosire, Rose Nuvor, Samuel Victor Choi, Robert Y. Mackelprang, Romel D. Kiarie, James N. De Rosa, Stephen C. Richardson, Barbra A. John-Stewart, Grace C. |
Keywords: | HIV-1 Enzyme-Linked Immunosorbent Uninfected Partners Low-Risk Controls |
Issue Date: | 2012 |
Publisher: | Clinical and Vaccine Immunology |
Abstract: | A number of studies of highly exposed HIV-1-seronegative individuals (HESN) have found HIV-1-specific cellular responses. However, there is limited evidence that responses prevent infection or are linked to HIV-1 exposure. Peripheral blood mononuclear cells (PBMC) were isolated from HESN in HIV-1-discordant relationships and low-risk controls in Nairobi, Kenya. HIV-1- specific responses were detected using gamma interferon (IFN-g) enzyme-linked immunosorbent spot (ELISpot) assays stimulated by peptide pools spanning the subtype A HIV-1 genome. The HIV-1 incidence in this HESN cohort was 1.5 per 100 person years. Positive ELISpot responses were found in 34 (10%) of 331 HESN and 14 (13%) of 107 low-risk controls (odds ratio [OR] 5 0.76; P 5 0.476). The median immunodominant response was 18.9 spot-forming units (SFU)/106 peripheral blood mononuclear cells (PBMC). Among HESN, increasing age (OR 5 1.24 per 5 years; P 5 0.026) and longer cohabitation with the HIV-1-infected partner (OR 5 5.88 per 5 years; P 5 0.003) were associated with responses. These factors were not associated with responses in controls. Other exposure indicators, including the partner’s HIV-1 load (OR 5 0.99 per log10 copy/ml; P 5 0.974) and CD4 count (OR 5 1.09 per 100 cells/ml; P 5 0.238), were not associated with responses in HESN. HIV-1-specific cellular responses may be less relevant to resistance to infection among HESN who are using risk reduction strategies that decrease their direct viral exposure |
URI: | http://hdl.handle.net/123456789/9577 |
Appears in Collections: | School of Medical Sciences |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Clinical and Vaccine Immunology-2012-Guthrie-1798.full.pdf | MAIN ARTICLE | 257.62 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.